Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Differential regulation of lymphokine production by distinct subunits of the T cell interleukin 2 receptor.
S Burdach, … , D Thompson, L Levitt
S Burdach, … , D Thompson, L Levitt
Published June 1, 1991
Citation Information: J Clin Invest. 1991;87(6):2114-2121. https://doi.org/10.1172/JCI115242.
View: Text | PDF
Research Article

Differential regulation of lymphokine production by distinct subunits of the T cell interleukin 2 receptor.

  • Text
  • PDF
Abstract

Most biologic responses to IL-2 have been attributed to interaction of IL-2 with a high affinity receptor which consists of a heterodimer composed of two distinct IL-2-binding proteins (IL-2R alpha/IL-2R beta). However, both low affinity IL-2R alpha (55 kD) and intermediate affinity IL-2R beta (70-75 kD) also appear to be expressed independently on the cell surface. We investigated the receptor-specific regulatory effects of IL-2 on cytokine production in unstimulated and activated T cells. T cells were activated by stimulation of the antigen receptor complex with anti-CD3 mAb. IL-2 (10(2) U/ml, 1 nM) stimulation of resting cells resulted in a fivefold increase in GM-CSF release but in only minimal IFN-gamma release. IL-2 markedly augmented mRNA expression of GM-CSF but not IFN-gamma in unstimulated T cells. IL-2R beta mAb but not IL-2R alpha mAb decreased IL-2-induced GM-CSF release and mRNA expression from unstimulated T cells. IL-2 concentrations required for GM-CSF release from resting cells suggested ligand binding to an intermediate affinity receptor. GM-CSF and IFN-gamma release from activated T cells increased four- to fivefold in response to 1 nM IL-2 and IL-2 augmented both GM-CSF and IFN-gamma mRNA. IL-2R beta mAb but not IL-2R alpha mAb reduced GM-CSF release and mRNA expression in activated T cells stimulated with 1 nM IL-2. IL-2R alpha blockade markedly decreased IL-2-induced IFN-gamma release and mRNA expression from activated cells, while IL-2R beta blockade had little effect on IFN-gamma production in activated cells. IL-2R alpha blockade altered the affinity of the receptor mediating activated cell GM-CSF release from a high affinity to an intermediate affinity state. These studies indicate an independent role for IL-2R beta in mediating GM-CSF production from T cells. They also suggest that unstimulated and activated T cells, which express distinct IL-2 receptor moieties, mediate release of separate lymphokines and that different subunits of the IL-2 receptor may play an important role in the regulation of cytokine production.

Authors

S Burdach, N Zessack, D Dilloo, M Shatsky, D Thompson, L Levitt

×

Total citations by year

Year: 2022 2018 2014 2009 2002 2000 1997 1996 1995 1994 1993 1992 Total
Citations: 1 1 1 2 1 1 1 3 2 3 2 8 26
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (26)

Title and authors Publication Year
Efficacy and antitumor activity of a mutant type of interleukin 2.
Dehghan R, Beig Parikhani A, Zeinali S, Shokrgozar M, Amanzadeh A, Ajdary S, Ahangari Cohan R, Talebkhan Y, Behdani M
Scientific Reports 2022
Immune cells regulate VEGF signalling via release of VEGF and antagonistic soluble VEGF receptor-1: Immune cells regulate VEGF signalling
T Hoeres, M Wilhelm, M Smetak, E Holzmann, G Schulze-Tanzil, J Birkmann
Clinical & Experimental Immunology 2018
Multiple sclerosis-associated IL2RA polymorphism controls GM-CSF production in human TH cells
FJ Hartmann, M Khademi, J Aram, S Ammann, I Kockum, C Constantinescu, B Gran, F Piehl, T Olsson, L Codarri, B Becher
Nature Communications 2014
CD25 Blockade protects T Cells from Activation-induced Cell Death (AICD) via Maintenance of TOSO Expression
GH Richter, A Mollweide, K Hanewinkel, C Zobywalski, S Burdach
Scandinavian Journal of Immunology 2009
Multiple Sclerosis
W Kim, HJ Kim
Journal of the Korean Medical Association 2009
Chemokines and Cancer
K Flanagan, HL Kaufman
Cancer Investigation 2002
Transplantation in Hematology and Oncology
WE Berdel, T Büchner, J Kienast, JV Loo, H Jürgens, J Ritter, J Vormoor
2000
Human pulmonary alveolar proteinosis associated with a defect in GM-CSF/IL-3/IL-5 receptor common beta chain expression
U Dirksen, R Nishinakamura, P Groneck, U Hattenhorst, L Nogee, R Murray, S Burdach
Journal of Clinical Investigation 1997
Interleukin-2 and human immunodeficiency virus infection: Pathogenic mechanisms and potential for immunologic enhancement
A Kinter, AS Fauci
Immunologic Research 1996
Activation of the HIV Type 1 Long Terminal Repeat by X-Irradiation Involves Two Main Rel/NF-κB DNA-Binding Complexes
E Faure, P Lecine, J Imbert, S Champion
AIDS Research and Human Retroviruses 1996
Production of granulocyte-macrophage colony-stimulating factor by T cells is regulated by B7 and IL-1 beta
M Kruger, SV Gool, XH Peng, L Coorevits, MC Daele, JL Ceuppens
Immunology 1996
Granulocyte-macrophage-colony stimulating factor for prevention of neutropenia and infections in children and adolescents with solid tumors. Results of a prospective randomized study
SE Burdach, M Müschenich, W Josephs, J Frisch, G Schulz, H Jürgens, U Göbel
Cancer 1995
Differential inhibition of lymphokine-activated killing, proliferation, and cytokine secretion by humanized antibodies against the low- and intermediate-affinity interleukin-2 receptors
KM Heaton, EA Grimm
Human Immunology 1995
Independent expression of p55 and p75 interleukin-2 receptors (IL-2R) during intravenous or subcutaneous administration of recombinant interleukin-2 (rIL-2) by T-lymphocytes and natural killer cells
R Zambello, L Trentin, A Cerutti, C Enthammer, A Milani, T Franceschi, C Messina, GL Cetto, C Agostini, G Semenzato
Cancer 1994
Endogenous Production and Peripheral Blood Levels of Granulocyte-Macrophage (GM - ) and Granulocyte (G - ) Colony-Stimulating Factors
B Sallerfors
Leukemia & Lymphoma 1994
Purification and characterization of a multicomponent AP-1.junD complex from T cells. Dependence on a separate cellular factor for enhanced DNA binding activity
K Gardner, TC Moore, T Davis-Smyth, H Krutzsch, D Levens
The Journal of biological chemistry 1994
Anti-CD26 monoclonal antibodies can reversibly arrest human T lymphocytes in the late G1 phase of the cell cycle
T Mattern, S Ansorge, HD Flad, AJ Ulmer
Immunobiology 1993
Alpha-interferon enhances gamma-interferon production of peripheral blood mononuclear cells pre-activated with phytohemagglutinin
K Katayama, N Hayashi, T Takehara, K Suzuki, A Kasahara, H Fusamoto, T Kamada
Gastroenterologia Japonica 1993
The interleukin-2/interleukin-2 receptor system: structural, immunological, and clinical features
G Semenzato, G Pizzolo, R Zambello
International Journal of Clinical & Laboratory Research 1992
Granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) secretion by adherent monocytes measured by quantitative immunoassays
B Sallerfors, T Olofsson
European Journal of Haematology 1992
Molecular regulation of hematopoietic cytokines: Implications and indications for clinical use in pediatric oncology
S Burdach
Medical and Pediatric Oncology 1992
Hexadecylphosphocholine induces interferon-γ secretion and expression of GM-CSF mRNA in human mononuclear cells
CH Hochhuth, K Vehmeyer, H Eibl, C Unger
Cellular Immunology 1992
Highly concentrated urine-purified Tac peptide fails to inhibit IL-2-dependent cell proliferation in vitro
G Pizzolo, C Vincenzi, F Vinante, A Rigo, D Veneri, M Chilosi, S Dusi, G Poli, R Zambello, G Semenzato, G Berton
Cellular Immunology 1992
The response of human decidual leukocytes to IL-2
A King, R Wheeler, NP Carter, DP Francis, YW Loke
Cellular Immunology 1992
Effects of alpha-interferon on gamma-interferon production of peripheral blood mononuclear cells in hepatitis B virus carriers
K Katayama, N Hayashi, T Takehara, T Towata, A Kasahara, H Fusamoto, T Kamada
Journal of Clinical Immunology 1992
Inducible expression of granulocyte-macrophage colony-stimulating factor, tumor necrosis FACTOR-α, and INTERFERON-γ in two human cytotoxic leukemic T-cell lines
A Cesano, D Santoli
In Vitro Cellular & Developmental Biology – Animal 1992

← Previous 1 2 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts